Failure of lipid emulsion to reverse neurotoxicity after an ultrasound-guided axillary block with ropivacaine and mepivacaine.
Calenda
Emile
E
Dinescu
Stelian A
SA
D000368:Aged; D000577:Amides / Q000008:administration & dosage / Q000009:adverse effects*; D000779:Anesthetics, Local / Q000008:administration & dosage / Q000009:adverse effects*; D001365:Axilla / Q000000981:diagnostic imaging*; D001921:Brain / Q000000981:diagnostic imaging; D004562:Electrocardiography / Q000187:drug effects; D005217:Fat Emulsions, Intravenous / Q000627:therapeutic use*; D005543:Forearm Injuries / Q000601:surgery; D006801:Humans; D008297:Male; D008619:Mepivacaine / Q000008:administration & dosage / Q000009:adverse effects*; D009407:Nerve Block / Q000009:adverse effects*; D020258:Neurotoxicity Syndromes / Q000175:diagnosis / Q000188:drug therapy* / Q000503:physiopathology; D000077212:Ropivacaine; D014057:Tomography, X-Ray Computed; D014463:Ultrasonography
D000577:Amides; D000779:Anesthetics, Local; D005217:Fat Emulsions, Intravenous; D000077212:Ropivacaine; D008619:Mepivacaine
Anaesthesia. 2006 Nov;61(11):1117; author reply 1117-8
17042856
Anaesthesia. 2006 Aug;61(8):800-1
16867094
Anesthesiology. 2007 Mar;106(3):636-7; author reply 637-8
17325531
Anesth Analg. 2008 May;106(5):1572-4, table of contents
18420879
Toxicol Rev. 2006;25(3):139-45
17192120
Ann Pharmacother. 2007 Nov;41(11):1873-7
17895327